Newly Diagnosed Acute Myeloid Leukemia Patients-Derived Bone Marrow Mesenchymal Stem Cells Suppress Daunorubicin Induced HL-60 Cell Apoptosis via Modulating Caspase-3/Survivin.
10.7534/j.issn.1009-2137.2019.06.005
- Author:
Hong-Mei NING
1
;
Jun WANG
1
;
Yong-Feng SU
1
;
Chen XU
1
;
Jiang-Wei HU
1
;
Xiao LOU
1
;
Xiu-Sen LI
2
;
Ning MAO
3
;
Hu CHEN
4
Author Information
1. Department of Hematopoietic Stem Cell Transplantation, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071,China.
2. Institute of Military Cognition and Brain Sciences, Academy of Military Medical Sciences, Beijing 100850, China.
3. Institute of Military Cognition and Brain Sciences, Academy of Military Medical Sciences, Beijing 100850, China,E-mail: maoning@nic.bmi.ac.cn.
4. Department of Hematopoietic Stem Cell Transplantation, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071,China,E-mail: chenhu217@aliyun.com.
- Publication Type:Journal Article
- MeSH:
Apoptosis;
Bone Marrow Cells;
Caspase 3;
Cell Proliferation;
Daunorubicin;
HL-60 Cells;
Humans;
Leukemia, Myeloid, Acute;
Mesenchymal Stem Cells;
Survivin
- From:
Journal of Experimental Hematology
2019;27(6):1736-1741
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the role of bone marrow niche in the chemotherapy resistance of patient with acute myeloid leukemia (AML), and to investigate the effects of the MSCs on the apoptosis of HL-60 cell and its underlying mechanisms.
METHODS:MSCs were derived from the bone marrow of newly diagnosed AML patients (AML-MSCs) and health donors(MSCs) were co-cultured with HL-60 cells respectively. The apoptosis of HL-60 cells in the presence/absence of MSCs and/or Daunorubicin were determined by flow cytometry with Annexin V/PI double staining. In addition, the morphological features of HL-60 cells were observed by Wright-Giemsa staining, and the ratio of blasts and differentiated cells were counted. Furthermore, the expressions of apoptosis-related factors including Caspase-3, Caspase-8,Caspase-9 and Survivin were detected by Western blot.
RESULTS:The flow cytometry showed that there was no significant change in apoptosis of HL-60 cells co-cultured with MSC derived from healthy donors or AML patients. After adding Daunorubicin into different cultural systems, the apoptotic rates of HL-60, HL-60 co-cultured with normal MSCs and HL-60 co-cultured with AML-MSCs were (49.57±7.44)%, (30.72±4.05)% and (22.99±4.08)%, respectively, which showed that normal MSCs and AML-MSCs could remarkably supress Daunorubicin-induced HL-60 apoptosis, however, there was no statistically significant difference of apoptosis between HL-60 co-cultured with normal MSCs and HL-60 co-cultured with AML-MSCs. Wright-Giemsa staining showed that most of the HL-60 cells co-cultured with AML-MSCs were primitive, and cell differentiation was unusual. In AML-MSCs co-cultured group, the cell apoptosis and differentiation caused by DNR was significant decreased, and most of HL-60 cells were initial. Western blot showed that the cleavage activity of Caspase-3 of HL-60 in AML-MSCs and normal MSCs co-cultured group was decreased, compared with HL-60 in single cultured group, moreover, the decrease was significantly in AML-MSC group. Additionally, the expression of survivin in AML-MSCs and normal MSCs co-cultured group was increased, compared with that in single cultured group, and increase was significant in AML-MSCs group.
CONCLUSION:MSCs can suppress Daunorubicin-induced HL-60 apoptosis via inhibiting Caspase-3 and maintaining survivin level.
